publication . Article . 2008

New technologies in contraception.

Sam Rowlands;
Open Access
  • Published: 12 Dec 2008 Journal: BJOG: An International Journal of Obstetrics & Gynaecology, volume 116, pages 230-239 (issn: 1470-0328, Copyright policy)
  • Publisher: Wiley
  • Country: United Kingdom
Abstract
New technologies in both reversible contraception and sterilisation are described. The review includes recent advances in the development of oral contraception, emergency contraception, injectable contraception, vaginal rings, subdermal implants, transdermal contraception, intrauterine devices, spermicides and barrier methods. It also covers methods of transcervical female sterilisation and more easily reversible male sterilisation. The emphasis is on the technology and its safety and effectiveness. Hormonal delivery systems are described in some detail. Mention is also made of research into vaccines and male hormonal methods, where progress has been disappointi...
Subjects
free text keywords: Obstetrics and Gynaecology, RG
Related Organizations
46 references, page 1 of 4

(17) Anderson FD, Gibbons W, Portman D. Long-term safety of an extendedcycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. Am J Obstet Gynecol 2006; 195:92-96.

(18) Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 2006; 74:439-445.

(19) Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ. Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception 2006; 74:100-103. [OpenAIRE]

(20) Nakajima ST, Archer DF, Ellman H. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ ethinyl estradiol 20 microg (Loestrin 24 Fe). Contraception 2007; 75:16-22.

(21) Fenton C, Wellington K, Moen MD, Robinson DM. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris. Drugs 2007; 67:1749-1765.

(22) Lakha F, Ho PC, Van der Spuy ZM, Dada K, Elton R, Glasier AF et al. A novel estrogen-free oral contraceptive pill for women: multicentre, doubleblind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel). Hum Repro 2007; 22:2428-2436.

(23) Pei K, Xiao B, Jing X, Lu S, Wei L, Zhao H. Weekly contraception with mifepristone. Contraception 2007; 75:40-44.

(24) Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2007; 92:3582-3589.

(25) Den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormonal replacement therapy use. Contraception 1999; 59:357-362.

(26) Glasier AF, Smith KB, Van der Spuy ZM, Ho PC, Cheng L, Dada K et al. Amenorrhoea associated with contraception: an international study on acceptability. Contraception 2003; 67:1-8.

(28) von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360:1803- 1810.

(29) Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006; 108:1089-1097. [OpenAIRE]

(30) Gemzell-Danielsson K, Marions L. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. Human Reproduction Update 2004; 10:341-348.

(31) Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser IS. Effectiveness of levonorgestrel emergency contraception given before or after ovulation - a pilot study. Contraception 2007; 75:112-118.

(32) Massai MR, Forcelledo ML, Brache V, Tejada AS, Salvatierra AM, Reyes MV et al. Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Hum Repro 2007; 22:434-439.

46 references, page 1 of 4
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue